A man wearing a protective face mask walks past the logo of Sanofi at the company’s headquarters in Paris, France, April 24, 2020. REUTERS/Charles Platiau/Files
PARIS (Reuters) – Healthcare company Sanofi Aventis France (SASY.PA) said on Monday that it had been placed under investigation on charges, including manslaughter, over Depakine – a medication known to have caused birth malfunctions in some cases.
Sanofi Aventis France added it had respected all its obligations regarding information provided on Depakine, and that it denied the charges.
Reporting by Sudip Kar-Gupta; editing by Jason Neely